Cannabis stocks have been hit hard in recent years, with the AdvisorShares Pure US Cannabis ETF losing over 90% of its value in the past five years. However, the author suggests that companies like Curaleaf and Trulieve may be worth considering as long-term investments, as they are generating positive cash flow despite profitability challenges. The industry faces risks from lack of federal legalization and banking access, but could see significant upside if legalization progresses.
The Motley Fool
